ENDRA Life Sciences Inc
NDRA
Company Profile
Business description
ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.
Contact
3600 Green Court
Suite 350
Ann ArborMI48105-1570
USAT: +1 734 335-0468
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2026
Employees
11
Stocks News & Analysis
stocks
The World Cup stock you’ve never heard of
This ASX stock is kicking goals at the FIFA World Cup.
stocks
Chart of the Week: Can WiseTech shares finally bounce back?
Market concerns over governance and AI fears have left shares trading well below the fair value.
stocks
Steep downgrade for wide moat share
Regulatory pressures squeeze growth outlook for wide moat ASX share.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,961.30 | 46.50 | 0.52% |
| CAC 40 | 8,273.77 | 21.11 | 0.26% |
| DAX 40 | 24,954.88 | 57.43 | 0.23% |
| Dow JONES (US) | 52,348.39 | 576.76 | -1.09% |
| FTSE 100 | 10,423.51 | 65.53 | -0.62% |
| HKSE | 24,030.18 | 169.28 | -0.70% |
| NASDAQ | 25,870.65 | 51.96 | 0.20% |
| Nikkei 225 | 67,743.85 | 924.80 | 1.38% |
| NZX 50 Index | 13,785.67 | 120.49 | 0.88% |
| S&P 500 | 7,482.71 | 21.14 | -0.28% |
| S&P/ASX 200 | 8,762.50 | 44.40 | 0.51% |
| SSE Composite Index | 4,036.59 | 65.71 | 1.65% |